A Study of the Pan-KRAS Inhibitor LY4066434 in Participants With KRAS Mutant Solid Tumors
Eli Lilly and Company
Eli Lilly and Company
Varian, a Siemens Healthineers Company
Kestrel Therapeutics, Inc.
National Institutes of Health Clinical Center (CC)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Montefiore Medical Center
SWOG Cancer Research Network
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Travera Inc
Nammi Therapeutics Inc
National Cancer Institute (NCI)
National Institutes of Health Clinical Center (CC)
Revolution Medicines, Inc.
AstraZeneca
Memorial Sloan Kettering Cancer Center
Conjupro Biotherapeutics, Inc.
Avera McKennan Hospital & University Health Center
Whitehawk Therapeutics, Inc.